Coffee Does Not Solve RLS—It May Actually Worsen It
Coffee and caffeine should be avoided or significantly reduced in patients with restless legs syndrome, as caffeine is recognized as a potential trigger that can worsen symptoms rather than alleviate them.
Why Coffee Is Not a Treatment for RLS
The most recent 2025 American Academy of Sleep Medicine (AASM) clinical practice guidelines make no mention of coffee or caffeine as a therapeutic option for RLS 1. Instead, the evidence points in the opposite direction:
Caffeine as a Trigger, Not a Treatment
- Historical evidence from 1978 identified caffeine as a major etiological factor in causing restless legs syndrome, noting that caffeine increases nervous system arousal and has direct peripheral contractile effects on striated muscle 2
- Clinical recommendations from 2017 explicitly state that reducing caffeine intake is recommended as part of RLS management 3
- Older clinical guidance from 2000 lists caffeine as a likely trigger that can worsen RLS symptoms 4
Recent Contradictory Data Requires Context
A 2025 study among medical students found a paradoxical correlation where higher caffeine consumption was associated with milder RLS symptoms (r = -0.383, p < 0.01), but this same study showed caffeine worsened sleep quality (r = 0.197, p < 0.01) 5. This is problematic because:
- Poor sleep itself worsens RLS symptoms, creating a vicious cycle
- The study was limited to a specific population (medical students) under unique stressors
- The correlation does not establish causation and may reflect confounding factors
- Morning caffeine showed better outcomes than evening use, but still impaired sleep quality overall 5
What Actually Works: Evidence-Based RLS Treatment
The 2025 AASM guidelines provide clear first-line recommendations 1:
Strong Recommendations (First-Line):
- Gabapentin enacarbil (strong recommendation, moderate certainty)
- Gabapentin (strong recommendation, moderate certainty)
- Pregabalin (strong recommendation, moderate certainty)
- IV ferric carboxymaltose for appropriate iron status (strong recommendation, moderate certainty)
Conditional Recommendations (Second-Line):
- Ferrous sulfate for oral iron supplementation when iron stores are low
- Extended-release oxycodone and other opioids (conditional recommendation, moderate certainty)
- Bilateral high-frequency peroneal nerve stimulation (conditional recommendation, moderate certainty)
Dopamine Agonists Are Now Discouraged
The guidelines suggest against standard use of pramipexole, ropinirole, rotigotine, and levodopa due to long-term augmentation risk (worsening symptoms with continued use) 1, 6, 7. These may only be considered for short-term use in select patients who prioritize immediate symptom relief over long-term safety.
Clinical Approach
Step 1: Check iron status
- Measure ferritin and transferrin saturation
- If ferritin < 75 ng/mL or transferrin saturation < 20%, initiate iron supplementation
- Consider IV iron (ferric carboxymaltose) for faster repletion in moderate-to-severe cases
Step 2: Eliminate triggers
- Reduce or eliminate caffeine intake, especially after noon
- Avoid alcohol
- Review medications that may worsen RLS (antihistamines, antidepressants, antipsychotics)
Step 3: Initiate pharmacotherapy if needed
- Start with α2δ calcium channel ligands: gabapentin enacarbil (preferred), gabapentin, or pregabalin
- Reserve opioids for refractory cases
- Avoid dopamine agonists as first-line therapy
Common Pitfall
Do not recommend coffee or caffeine as a treatment strategy for RLS. While one recent study showed a correlation between higher caffeine use and milder RLS symptoms in medical students, this finding contradicts decades of clinical experience and guideline recommendations. The same study demonstrated that caffeine worsens sleep quality, which independently exacerbates RLS symptoms. The risk-benefit analysis clearly favors caffeine reduction, not consumption.